StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma total assets

Total assets on the balance sheet at the end of each period.

Regen BioPharma's total assets was $287.59K at Jun 30, 2026. For fiscal 2025 it was $274.63K, up 70.5% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $1.21M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025$274.63K+70.5%
FY2024Sep 30, 2024$161.08K-54.4%
FY2023Sep 30, 2023$353.62K-36.7%
FY2022Sep 30, 2022$559.00K-53.9%
FY2021Sep 30, 2021$1.21M+883.9%
FY2020Sep 30, 2020$123.19K+24.3%
FY2019Sep 30, 2019$99.09K-52.6%
FY2018Sep 30, 2018$209.02K-77.9%
FY2017Sep 30, 2017$944.24K+195.7%
FY2016Sep 30, 2016$319.36K+44.9%
FY2015Sep 30, 2015$220.45K+1969.0%
FY2014Sep 30, 2014$10.66K-90.8%
FY2013Sep 30, 2013$115.92K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$287.59K+46.1%
Q2 FY2026CQ1 2026Mar 31, 2026$260.19K+53.5%
Q1 FY2026CQ4 2025Dec 31, 2025$237.08K+23.9%
Q4 FY2025CQ3 2025Sep 30, 2025$274.63K+70.5%
Q3 FY2025CQ2 2025Jun 30, 2025$196.84K+15.7%
Q2 FY2025CQ1 2025Mar 31, 2025$169.48K+20.4%
Q1 FY2025CQ4 2024Dec 31, 2024$191.42K+20.0%
Q4 FY2024CQ3 2024Sep 30, 2024$161.08K-54.4%
Q3 FY2024CQ2 2024Jun 30, 2024$170.15K-40.3%
Q2 FY2024CQ1 2024Mar 31, 2024$140.77K-65.4%
Q1 FY2024CQ4 2023Dec 31, 2023$159.53K-61.5%
Q4 FY2023CQ3 2023Sep 30, 2023$353.62K-36.7%
Q3 FY2023CQ2 2023Jun 30, 2023$285.20K-58.6%
Q2 FY2023CQ1 2023Mar 31, 2023$406.64K-35.5%
Q1 FY2023CQ4 2022Dec 31, 2022$414.11K-43.7%
Q4 FY2022CQ3 2022Sep 30, 2022$559.00K-53.9%
Q3 FY2022CQ2 2022Jun 30, 2022$689.69K-51.9%
Q2 FY2022CQ1 2022Mar 31, 2022$630.87K+254.4%
Q1 FY2022CQ4 2021Dec 31, 2021$735.24K+388.2%
Q4 FY2021CQ3 2021Sep 30, 2021$1.21M+883.9%
Q3 FY2021CQ2 2021Jun 30, 2021$1.43M+1401.6%
Q2 FY2021CQ1 2021Mar 31, 2021$178.02K+86.5%
Q1 FY2021CQ4 2020Dec 31, 2020$150.60K+267.3%
Q4 FY2020CQ3 2020Sep 30, 2020$123.19K+24.3%
Q3 FY2020CQ2 2020Jun 30, 2020$95.48K-16.5%
Q2 FY2020CQ1 2020Mar 31, 2020$95.48K+117.5%
Q1 FY2020CQ4 2019Dec 31, 2019$41.01K-77.5%
Q4 FY2019CQ3 2019Sep 30, 2019$99.09K-52.6%
Q3 FY2019CQ2 2019Jun 30, 2019$114.30K-79.5%
Q2 FY2019CQ1 2019Mar 31, 2019$43.89K-94.2%
Q1 FY2019CQ4 2018Dec 31, 2018$182.25K-84.1%
Q4 FY2018CQ3 2018Sep 30, 2018$209.02K-77.9%
Q3 FY2018CQ2 2018Jun 30, 2018$558.81K-42.1%
Q2 FY2018CQ1 2018Mar 31, 2018$757.06K+26.5%
Q1 FY2018CQ4 2017Dec 31, 2017$1.15M+62.6%
Q4 FY2017CQ3 2017Sep 30, 2017$944.24K+195.7%
Q3 FY2017CQ2 2017Jun 30, 2017$965.56K–
Q2 FY2017CQ1 2017Mar 31, 2017$598.50K–
Q1 FY2017CQ4 2016Dec 31, 2016$706.66K–
Q4 FY2016CQ3 2016Sep 30, 2016$319.36K–

More Regen BioPharma figures

See a number that looks wrong?